and further delineate the heterogeneity of tumour-associated antigens in this human tumour system.
The search for antigens associated with human tumours (TAA) continues to be a field attracting much interest. Although it is becoming increasingly clear that TAAs are rarely, if ever, completely tumour restricted, quantitative differences in antigen expression between malignant and normal cells have often proved to be sufficient to make them valuable in the diagnosis and therapy of some tumours (Deland & Goldenberg, 1983; Mach et al., 1983; Larson et al., 1983; Sears et al., 1984) . In addition, information regarding the function of these molecules may be important for the understanding of their possible role in oncogenesis.
Recent reports on different tumour antigens associated with urinary bladder cancer (Fradet et al., 1984; Mazuko et al., 1984; Koho et al., 1984; Messing et al., 1984; Grossman, 1983) suggest the existence of a complex group of TAAs similar to what has been found for melanomas (for review see Hellstr6m et al., 1985) . In this study we describe the production and specificity patterns of two new monoclonal antibodies extending our earlier analysis of the heterogeneity of TAAs in human bladder carcinoma. The monoclonal antibodies tested were secreted by hybridomas obtained from Balb/c mice immunized with cells from 2 different TCC cell lines (TCCSuP and SD) . By means of a Correspondence: H. Ben-Aissa. Received 30 July 1984; and in revised form 18 March 1985. cell-ELISA, indirect immunofluorescence (IFL) and immunoperoxidase staining, the specificities of these antibodies were investigated against a panel of cells as well as tissue of normal or tumour origin. The antigens recognized by the antibodies were defined by immunoprecipitation followed by SDS-PAGE and autoradiography.
Materials and methods Cell lines and tissues
The target cells used in the cell-ELISA and IFL are given in Table I . The culturing conditions and other data for these cells have been given elsewhere .
Surgical specimens were collected immediately after surgery, snap frozen in liquid nitrogen and stored at -70°C until sectioned. Enzyme linked immunosorbent assay (ELISA) This assay was a modification of the method originally reported by Engvall & Perlmann (1971) and described in detail by Koho et al. (1984) . In a few cases in which conjugates based on alkaline phosphatase (ALP) could not be used because of endogeneous ALP activity of the target cells, horseradish peroxidase linked sheep F(ab') anti-mouse immunoglobulin (Amersham, Bucks., UK) was used as conjugate in the ELISA assay. In these cases, the reactions were revealed by addition of 100 M1 of 2,2'-azino-di-3-ethylbenzthiazoline sulfonate.
Indirect immunofluorescence and immunoperoxidase assays The binding specificities of the antibodies were determined against cultured cells, adhered to multitest slides, by IFL as described elsewhere . The specificity of antibodies was also analysed by IFL and immunoperoxidase (Nakane & Pearce, 1966) on frozen sections of human tumours and normal tissue. Six to 8 um thick cryostat sections were fixed for 5min with 1% formaldehyde in PBS, washed extensively in buffer with 1% bovine serum albumin and incubated with 10 times diluted hybridoma supernatant for 30min.
For IFL, the slides were washed and incubated for an additional 30min with rabbit F(ab')2 anti-mouse immunoglobulin (Ig) conjugated to fluorescein isothiocyanate (Clark & Shepard, 1963) , washed again and mounted in 50% glycerol in PBS prior to examination. For immunoperoxidase staining, the slides were incubated with sheep F(ab')2 anti-mouse Immunoprecipitation and SDS-PAGE analysis of target components Immunoprecipitation was performed essentially as described earlier by Paulie et al. (1984) . Briefly, Nonidet P-40 solubilized extracts of cells labelled with 1251 by the glucose oxidase/lactoperoxidase method (Schenkein et al., 1972) were used. Cellular antigens from total lysates or from ConA-binding and ConA-passed fractions (Paulie et al., 1983) were bound to antibodies on a protein-A sepharose 4B matrix (Pharmacia Fine Chemicals, Uppsala, Sweden) and separated by SDS-PAGE. The gels were subjected to autoradiography and the mol wts of precipitated molecules were calculated from their mobility in relation to standard proteins.
Results
Several fusions with the purpose of producing hybridomas secreting antibodies specific for antigens associated with transitional cell carcinoma of the human urinary bladder (TCC) were performed. The two immunizing cell lines were (i) SD, established in our laboratory from a TCC of grade 3 malignancy (Paulie et al., 1983) and (ii) TCCSuP, derived from an undifferentiated grade 4 TCC (Nayak et al., 1977) . In two fusions of spleen cells from mice immunized either with TCCSup or SD, growing hybridomas were selected for antibody production against the immunizing cell lines. A low percentage (16 and 20%) of these showed positive reactions against TCCSup and SD respectively.
When tested against cells of non-TCC origin (2T, LS174T, Ulf and peripheral blood lymphocytes) two hybridomas (P7A5-4 and SK4H-12) produced antibodies with little or no activity against these controls. These were cloned 3 times. As shown by immunodiffusion against subclass specific rabbit antisera, antibodies from P7A5-4 were of the IGgl isotype while SK4H-12 were IgG2a. Crude supernatants from both hybridomas gave significant OD values in ELISA up to a dilution of 1: 104 and reaching maximum levels at 1:102 dilution. Reactivities to components of the serum supplement in the culture medium were excluded by testing in ELISA against wells coated with serum proteins as well as by absorption of the antibodies with serum proteins coupled to Sepharose. Specificity of the two antibodies was further assessed against cell cultures and tissue sections by means of the three assays: ELISA, IFL and indirect immunoperoxidase. Monoclonal antibody SK4H-12 Table I shows the reactivity pattern of the SK4H-12 antibody (mouse immunized with SD). Positive ELISA reactions were observed with 6 of 7 TCC cell lines, 4 of which were also tested and found to be strongly stained in IFL. A strong positive fluorescence was also obtained with the bladder carcinoma of squamous cell origin (SCaBER). SK4H-12 also gave high OD values (405nm) and an intense staining with the normal urothelial cells. With the exceptions of the prostate carcinoma line (HS), which gave a weak reaction in ELISA and the melanoma line (Ulf) giving a weak staining in IFL, no reactivity was seen with any of the controls included in this study. Furthermore, SK4H-12 gave a homogeneous staining pattern of 7/8 bladder tumour specimens but so far and as shown in Table  II it did not stain any of the control tissues tested. One such reaction to a transitional cell carcinoma is illustrated in Figure 1 . 
Monoclonal antibody P7A5-4
The antibody P7A5-4 showed positive reactions with 5 out of 7 TCC cell lines, while little or no reactivity was observed with the two cells derived from normal urothelium (Table I) . Furthermore, positive ELISA and/or IFL results were obtained with the squamous carcinoma line (SCaBER), 2 of 3 colon carcinomas (HT29, HCT8), the 3 melanoma cell lines (Ulf, Mel-l and CRL-1585), a lung carcinoma cell line (A427), a prostatic carcinoma (HS) and lung fibroblasts. No reactivity was observed with the remaining controls. Results of tissue staining, summarized in Table II , show that 7 out of 8 bladder tumours tested were P7A5-4 positive. The reaction pattern was homogeneous while the intensity was moderate to strong. Among the control tissues, weak staining was associated with prostate epithelium as well as vessel endothelium in most cases. Furthermore, cryostat sections from both rat and rabbit organs (bladder, kidney, lung, liver, spleen, muscle, intestine, heart and stomach) were not stained by either of the 2 antibodies. Figure 2 illustrates the staining of a bladder carcinoma with the P7A5-4 antibody by immunoperoxidase.
Immunoprecipitation and SDS-PAGE analysis
To determine the cellular target structures for the 2 antibodies, precipitation was performed using NP-40 extracts of cells surface-labelled with 1251. The material bound to antibody-ProtA-Sepharose complexes was analysed on SDS-PAGE followed by autoradiography. Under reducing conditions, SK4H-12 precipitated a polypeptide with a mol. wt of -100 Kd present in extracts of SD and T24 cells (Figure 3) . A similar band but at a slightly lower mol. wt was observed under non-reducing conditions. Moreover, from experiments where the extracts had been divided into a ConA binding and 67 (50) +++ (90) +++ (50) +++ (60) +++ (30) +++ ( Figures within brackets = number of specimens stained. aEndothelium in most tissues was stained.
bHomogeneous reactivity pattern.
cStaining of epithelium lining the vesicle ducts.
= no staining. 
Discussion
The aim of this study was to raise antibodies specific for urinary bladder carcinoma and to elucidate whether these could define new structures of potential value for diagnosis and therapy. The immunizing schedule adopted was chosen to allow antigens of poor immunogenicity or low cellular expression to give rise to an immune response. For screening of hybridoma supernatants, we used IFL and a cell-ELISA similar to that described by Suter et al. (1980) . A detailed description of the cell-ELISA developed in our laboratory has been given elsewhere . Due to endogenous alkaline phosphatase activity or other reasons, some cell lines were tested in a peroxidase ELISA or only by IFL. Cryostat sections from frozen tissues were tested by IFL and an indirect immunoperoxidase staining method.
The occurrence of cross-contamination between urothelial cell lines has been discussed recently by O'Toole et al. (1983) . To establish the identity of the urothelial cell lines on our target cell panel, tests for HLAA,B specificity in ADCC (O'Toole et al., 1982) and HLA DR/DC specificity by DNA blotting and hybridization with cDNA probes (Andersson et al., 1984) , were performed (B. Karlsson et al., in preparation) . On the basis of these tests, 5 TCC cell lines, (T24, J82, SD, RT4, HU549) and 2 cell lines derived from normal urothelium (HU609 and HCV29) were clearly distinct from each other. When compared to T24, the 2 cell lines TCCSuP and EJ appeared to be identical in HLAA,B expression and homologous in the DR/DC loci. However, as they differed in growth pattern as well as morphology and displayed differences in antigen expression, they were included on our cell panel. The possibility that these 2 lines constitute sublines of T24 is not excluded.
When examining the antibody secreted by hybridoma SK4H-12 against a panel of cultured target cells, positive reactions were seen with 9/10 urothelium derived cells, including those of normal origin. From 25 non-urothelial cell types only 2 (HS and ULF) showed reactivity. The. significance of these reactions is, however, doubtful since reactivity in both cases was only observed with one of the two assays and gave values only slightly over background. Immunohistochemical staining of tissue sections with SK4H-12 showed a similar selective pattern of reactivity. While staining the majority of TCC specimens (7/8), no reaction has so far been detected with any of the non-TCC adult tissues included in this study. Interestingly and in contrast to what was seen for cultured cells, SK4H-12 gave no visible staining of normal urothelium. Although this has to be confirmed by testing further material from normal bladder, it suggests that the cells in culture may have acquired some phenotypic characters of malignant cells. A premalignant phenotype of these cells is also supported by an apparently indefinite lifespan. However, they lack the ability to grow in nude mice and show a diploid karyotype (Vilien et al., 1983) .
Results of the antigen studies presented herein show that the target antigen of SK4H-12 is a glycoprotein of mol. wt 100 Kd, present in lysates of both SD and T24 cells but absent from extracts of SK4H-12 negative cell lines (TCCSuP, HT29 and LS174-T).
The other antibody, P7A5-4, displayed a specificity pattern similar to that of three other TCC-related antibodies previously found in our laboratory . As these also precipitated polypeptides of the same molecular size, they are likely to be directed against the same target antigen. Differences in reactivity with individual cell lines suggest, however, that they recognize separate epitopes. The P7A5-4 antibody could clearly discriminate between malignant and normal cells from the bladder, both when tested with cultured cells and fresh tissue. On cell lines the antibody also showed a positive reactivity with some non-TCC and melanoma cells. However, for most of these cells the detected reactions were significantly lower indicating a quantitative difference in antigen expression by TCC and other cells. This difference in the level of expression was even more pronounced when tested with fresh tumours. A moderate to strong homogeneous staining was seen with 7 out of 8 TCC specimens while 8 non-related carcinomas as well as 5 melanomas failed to given any visible reaction. The P7A5-4 antigen was, however, not entirely restricted to TCC cells since a weak staining was also observed in association with the epithelium lining some of the vesicle ducts within the prostate as well as the vessel endothelium of some tissues. These reactivities have to be further elucidated, especially since the endothelium represented an area frequently seen to give elevated background staining. For this purpose we are presently setting up in vitro cultures of endothelial cells derived from the umbilical cord.
The major components precipitated with both of these antibodies, 100Kd for SK4H-12 and 92Kd for P7A5-4, are found in a molecular size range where TAAs of other tumours have previously been identified with mouse monoclonals. These include the 94 Kd polypeptide described by Imai et al. (1982) to be associated with melanomas and carcinomas and the p97 reported by two groups (Woodburry et al., 1980; Dippold et al., 1980) to be preferentially expressed on melanomas and some carcinomas. However, judging from the cellular distribution of these antigens as well as the lack of coprecipitated low molecular polypeptides, the 92 Kd as well as the 100 Kd appear to represent distinct antigens.
A difference in cellular restriction was also established for one of these melanoma-associated antigens, p97, when antibodies to this molecule (a gift from Dr K.E. Hellstrom) were tested in ELISA against the same cell panel. The two polypeptides appear also to be separate from the transferrin receptor, as antibodies to this molecule (OKT9, Sutherland et al., 1981 ) detect a polypeptide of -180 Kd when run on SDS-PAGE under nonreducing conditions and a band of slightly higher mol. wt (95 Kd) than the 92 Kd under reducing conditions (results not shown). Furthermore, similarity in molecular size between the major low mol. wt component (23 Kd) and the ras gene product p21 (Chang et al., 1982) known to be well expressed in some TCC cells, raised the question whether the two molecules might be identical. However, radiolabelled TCC cell extracts precipitated by antibodies to either the p21 or the 23 Kd molecules showed distinct migration profiles (G.M. Cooper, personal communications), thus suggesting a non-identity of these molecules.
Monoclonal antibodies reactive with TCC associated antigens have recently been reported by other groups (Fradet et al., 1984; Mazuko et al., 1984; Messing et al., 1984; Grossman, 1983) . However, comparison of these findings with our own data suggests that none of these antibodies is likely to be identical to the ones described herein. Within the limits and sensitivity of the tests performed in this study, the antigenic targets for the SK4H-12 and P7A5-4 antibodies were shown to be expressed in a highly selective manner. Both were found on a majority of TCC cells but were absent from normal urothelial tissue. Although the distributional pattern of the antigens makes them potentially useful as markers for bladder carcinoma, conclusions regarding specifity have to await further tests on various tissues of malignant, normal and foetal origin. 
